Distinguished in Vulvectomy

Annette Hasenburg

Untere Zahlbacher Str. 8, 
Mainz, RP, DE 
Distinguished in Vulvectomy
Untere Zahlbacher Str. 8, 
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Annette Hasenburg practices in Mainz, Germany. Ms. Hasenburg is rated as a Distinguished expert by MediFind in Vulvectomy. Her top areas of expertise are Vulvar Cancer, Ovarian Cancer, Breast Cancer, Vulvectomy, and Lymphadenectomy.

Her clinical research consists of co-authoring 221 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Vulvectomy.

Gender
Female

Locations

Untere Zahlbacher Str. 8, Mainz, RP 55131, Germany
Other Locations
Frauenklinik, Hugstetter Str. 55, Freiburg, BW 79106, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Enrollment Status: Terminated
Publish Date: March 20, 2025
Intervention Type: Drug
Study Drug: Trabectidin
Study Phase: Phase 4
Pazopanib Vs. Pazopanib Plus Gemcitabine in Patients with Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
Pazopanib Vs. Pazopanib Plus Gemcitabine in Patients with Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
Enrollment Status: Active_not_recruiting
Publish Date: November 15, 2024
Intervention Type: Drug
Study Drugs: Pazopanib, Gemcitabine
Study Phase: Phase 2
View 1 Less Clinical Trial

220 Total Publications

Heterotopic Pregnancy After Intracytoplasmic Sperm Injection With Viable Embryos: A Case Report and Literature Review.
Heterotopic Pregnancy After Intracytoplasmic Sperm Injection With Viable Embryos: A Case Report and Literature Review.
Journal: Cureus
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hasenburg's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile